rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Scienture Holdings, Inc.

SCNX · Nasdaq

Health CarePharmaceuticalsNot moving yet

SCNX stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 62.9% below that average now. Pharmaceuticals: 31% of its 74 stocks in an uptrend (−7 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
31% -7 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
14 (+1)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

17 Apr – 16 Oct
26%36%46%Apr 26Jun 26Jul 26Sep 26Oct 26

Pharmaceuticals: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders14+1 on the quarter
New · exited3 · 2
Reported value$646K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026510,391$179K+102,300+25.1%
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026334,967$117K-97,219−22.5%
SUSQUEHANNA INTERNATIONAL GROUP, LLPnew · filed 14 Aug 2026235,117$82K+235,117
VANGUARD FIDUCIARY TRUST COunchanged · filed 13 Aug 2026198,060$69K00.0%
CITADEL ADVISORS LLCnew · filed 14 Aug 2026164,854$58K+164,854
XTX Topco Ltdadded · filed 14 Aug 2026104,799$37K+57,119+119.8%
NORTHERN TRUST CORPadded · filed 13 Aug 202687,606$31K+73,712+530.5%
UBS Group AGreduced · filed 13 Aug 202685,915$30K-21,918−20.3%
JANE STREET GROUP, LLCadded · filed 14 Aug 202675,729$27K+48,093+174.0%
TWO SIGMA SECURITIES, LLCreduced · filed 14 Aug 202633,280$12K-3,165−8.7%
30 Sep 2024 – 30 Jun 2026
61014Sep 24Mar 25Sep 25Dec 25Jun 26

Everyone who traded it

Hariharan Shankar Company insiderCo-CEO & Chairman · last 20 Feb 20260 · 0
Mani Narasimhan Company insiderPresident & Co-CEO · last 20 Feb 20260 · 0
Eric Michael Sherb Company insiderChief Financial Officer · last 15 May 20250 · 0
Prashant Patel Company insiderInterim CFO and Director · last 5 Jan 20240 · 4
Surendra K. Ajjarapu Company insiderChairman and CEO · last 5 Jan 20242 · 1
Michael L. Peterson Company insiderDirector · last 16 Jan 20230 · 3
A. Jeffrey Newell Company insiderDirector · last 30 Dec 20220 · 0
Janet Huffman Company insiderCFO, PAO, PFO · last 13 Dec 20220 · 0
Charles L. Pope Company insiderDirector · last 1 Sep 20220 · 0
Donald G. Fell Company insiderDirector · last 1 Sep 20222 · 13
Christine L. Jennings Company insiderDirector · last 27 May 20210 · 0
Pamela Tenaerts Company insiderOther · last 27 May 20210 · 1

Same industry

ABBV AbbVieLeading+20%
VTRS ViatrisLeading+16%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202576.8%
Return on capital employedFY 2025 · to 31 Dec 2025-52.3%
Research spendFY 2025 · to 31 Dec 2025453%
Share count trendFY 2025 · to 27 Mar 20260.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$6.7M

Analyst forecasts

No analyst forecasts yet.